Hifdura combination subcutaneous injection, from Argenix Japan, contains Efgartigimod alfa (genetical recombination) / Borhyaluronidase alfa (genetical recombination). This injectable drug (YJ code: 6399501A1020) is provided as 5.6mL per bottle. It is designed as a combination therapy for conditions such as generalized myasthenia gravis (gMG).
Hifdura combination subcutaneous injection
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).